Biohaven Acquires Rights for BHV-8000 to Treat Immune-Mediated Brain Disorders
March 23, 2023
Biohaven to Acquire Channel Biosciences for ~$3B
February 28, 2022
Biohaven Entered into an Exclusive License and Research Agreement with KU Leuven to Develop and Commercialize BHV-2100 for Chronic...
January 10, 2022
Biohaven Reports Results of Zavegepant in P-III Study for the Treatment of Migraine
December 7, 2021
PharmaShots Weekly Snapshots (November 08, 12, 2021)
November 12, 2021
PharmaShots Weekly Snapshots (May 31 - June 4, 2021)
June 4, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.